We evaluated the efficacy of ensitrelvir for the treatment of cough due to coronavirus disease 2019 Omicron variant in medical healthcare workers. A total of 633 patients were registered in this study: 206 patients chose ensitrelvir and 427 patients chose symptomatic treatment. Difference in score changes using the Leicester Cough Questionnaire between groups was 3.17 on day 4, 3.24 on day 7, and 2.46 on day 14. The analysis demonstrated a significant difference at all time points.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459974 | PMC |
| http://dx.doi.org/10.1128/aac.01064-24 | DOI Listing |
Publication Analysis
Top Keywords
efficacy ensitrelvir
8
omicron variant
8
variant medical
8
medical healthcare
8
healthcare workers
8
patients chose
8
ensitrelvir cough
4
cough covid-19
4
covid-19 omicron
4
workers evaluated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!